November 2014 - The Reporter
On May 6, join a virtual 30-minute session exploring the Career Goals feature in LinkedIn Learning, an online learning resource platform available at no cost to all benefit-eligible employees at UAB. Register today.
Published in
Learning & Development
A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Semaglutide Once Weekly in Adult Participants with Type 2 Diabetes and Inadequate Glycemic Control with Metformin with or without SGLT2 Inhibitor (TRANSCEND-T2D-2)
TRANSCEND-T2D-2 is a clinical research study for people with type 2 diabetes.
This study will test if an investigational medicine (the medicine being studied) can
help with blood glucose (sugar) and weight management compared with an existing
treatment for type 2 diabetes.
- Are aged 18 years or older
- Have type 2 diabetes
- Have been taking 1500mg or more of metformin each day for at least 3 months (with or without SGLT2i)
- Have a BMI of 25 or more
- Have HbA1c levels of 7.0% to 10.5%
To see if you qualify please contact at 205-996-4015, 205-934-5564 or via mail at tthoma@uab.edu or ccnrn@uab.edu
Published in
Clinical Trials
April 29, 2024
UAB Learning & Development Learn to Win Challenge Returns
The Learn to Win challenge is a quarterly event that offers a curated learning path for UAB’s community of benefit-eligible learners. This quarter’s contest, “Learn to Win: Power Skills for Today and Tomorrow,” offers a chance to win prizes by completing a series of videos by May 31.
Published in
Learning & Development
April 24, 2024
Need new ideas? Try a walking meeting
Starting small and making a plan with a crew can help Blazers with desk jobs stay active — and one employee from the School of Education says walking meetings have changed the game for her and her team.
Published in
Be Healthy
April 24, 2024
Diagnosed with depression? Your mental health matters.
If you’ve been feeling stuck and longing for relief, you may be eligible to receive dedicated medical attention, an investigational therapeutic and compensation for your involvement in an innovative research study.
We're conducting clinical research in depression to learn how individuals’ brain biology impacts response to treatment, with the goal to help people find relief faster. You do not need to already have a diagnosis to participate.
If you’re currently taking medication, you are likely still eligible for our studies and don’t have to stop your existing treatment regimen.
For more information about this trial and to see if you qualify, please contact Kristine at kristinepike@uabmc.edu or 205-975-8542.
We're conducting clinical research in depression to learn how individuals’ brain biology impacts response to treatment, with the goal to help people find relief faster. You do not need to already have a diagnosis to participate.
If you’re currently taking medication, you are likely still eligible for our studies and don’t have to stop your existing treatment regimen.
For more information about this trial and to see if you qualify, please contact Kristine at kristinepike@uabmc.edu or 205-975-8542.
Published in
Clinical Trials
April 24, 2024
Are you currently or have you ever been depressed?
Major Depressive Disorder is a mental health condition characterized by periods of low mood, low self-esteem, and loss of interest or pleasure in normally enjoyable activities. The purpose of this clinical research study is to evaluate the safety and effectiveness of an investigational drug for Major Depressive Disorder, also known as Major Depression. Study participation may include several clinic visits over a period of up to 5 months with an opportunity to conduct some visits either virtually or in-clinic. Qualified participants will receive compensation for their time.
For more information about this trial and to see if you qualify, please contact Kristine at kristinepike@uabmc.edu or 205-975-8542.
For more information about this trial and to see if you qualify, please contact Kristine at kristinepike@uabmc.edu or 205-975-8542.
Published in
Clinical Trials
April 24, 2024
Project ATHENA: Integrated e-Health (Electronic Health) for HIV Prevention and Substance Use Disorders in Justice Involved Women
Are you:
You may qualify for a paid research study at the University of Alabama at Birmingham, in partnership with Yale University.
Call: (205) 934-2851 or Email: AthenaStudy@uabmc.edu
- A woman on parole, probation, or recently released from prison or jail?
- A woman who has used drugs?
- Interested in learning about a way to protect yourself against HIV?
You may qualify for a paid research study at the University of Alabama at Birmingham, in partnership with Yale University.
- Participate in confidential study interviews at our research office.
- Earn $50 for each interview, up to $225 for participating in the study.
Call: (205) 934-2851 or Email: AthenaStudy@uabmc.edu
Published in
Clinical Trials
April 18, 2024
Latest cohort graduates from Blaze Leadership Academy
Meet the 2023-2024 class of UAB’s flagship leadership academy for high-potential faculty and staff.
Published in
Learning & Development
Olakunle Alonge, M.D., Ph.D., an expert in implementation science, joined UAB in 2023 as the center’s new director. In July, it will host an intensive implementation research institute with an emphasis on health inequities.
Published in
Get Involved
April 15, 2024
A Study on Myopia (Nearsightedness)
Researchers from the UAB School of Optometry are currently recruiting those with myopia to participate in a research study. The purpose of this study is to investigate the short-term effects of image blur and wavelengths on the light on the length of the eye and thickness of the choroid. If you are eligible to participate in our study, you will attend two study visits. During each study visit, you will be asked to watch a short film. We will collect images and measurements of the eye during the film. Both study visits are expected to last 90 minutes. You will be compensated $100 for your time after you complete both visits.
If you are interested in learning more about this study, please contact Tiara Plymouth at tiaramp@uab.edu or 205-975-3881 or send an email to Dr. Safal Khanal at skhanal@uab.edu
If you are interested in learning more about this study, please contact Tiara Plymouth at tiaramp@uab.edu or 205-975-3881 or send an email to Dr. Safal Khanal at skhanal@uab.edu
Published in
Clinical Trials
